On December 19, Glonghui reported that the discount Weight Loss Drugs stock Hims & HERS fell 13% in Pre-Market Trading. Previously, the USA Food and Drug Administration (FDA) stated that the supply shortage of the Eli Lilly and Co Weight Loss Drugs injectable Tirzepatide has been addressed.
- Headlines
- The affordable Weight Loss Drugs concept stock Hims & HERS fell 13% in Pre-Market Trading.
平价减肥药概念股Hims & Hers美股盘前跌13%
The affordable Weight Loss Drugs concept stock Hims & HERS fell 13% in Pre-Market Trading.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
16:06
A rescue helicopter from the Turkish Ministry of Health has crashed, resulting in the deaths of 4 people.
16:04
The Israeli army claims to have launched an air strike against Hamas militants inside a school in Gaza.
15:46
The People's Insurance: Chairman Ding Xiangqun's qualifications have been approved.
The People's Insurance-0.81%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.